Fred H. Mermelstein
Founder at Pear Tree Pharmaceuticals, Inc.
Network origin in Fred H. Mermelstein first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
The Rogosin Institute, Inc.
 The Rogosin Institute, Inc. Medical/Nursing ServicesHealth Services The Rogosin Institute, Inc. engages in providing treatment for kidney diseases. The company was founded in 1983 and is headquartered in New York, NY.
21
| Non-Profit Organization | Medical/Nursing Services | 21 |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA.
18
| Subsidiary | Pharmaceuticals: Major | 18 |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021.
17
| Holding Company | Biotechnology | 17 |
| Public Company | Pharmaceuticals: Major | 15 | |
SanaRx Biotherapeutics, Inc.
 SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Pear Tree Pharmaceuticals, Inc.
 Pear Tree Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pear Tree Pharmaceuticals, Inc. operates as a development stage company with interests in developing prescription products for women. It offers products that treat and prevent diseases, symptoms, and conditions associated with menopause and cancer chemotherapy. The company was founded by Stephen Charles Rocamboli, Fred H. Mermelstein, Janet Chollet and Martin J. Driscoll in July 2007 and is headquartered in Auburndale, MA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
NX Development Corp.
 NX Development Corp. Medical SpecialtiesHealth Technology NX Development Corp. operates as a life science company. It develops Gleolan oral solutions which helps in identifying malignant glioma, a type of brain tumor in adult patients. It allows surgeons to visualize brain tumors during surgery. The company was founded by Alan Ezrin and is headquartered in Lexington, KY.
4
| Holding Company | Medical Specialties | 4 |
Innovative Drug Delivery Systems, Inc.
 Innovative Drug Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology IDDS is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical need in the pain management market. IDDS’s product candidates address the market segment for prescription medications focused on treating acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post operative pain, orthopedic injury, procedural pain, burn pain and trauma. The product candidates offer enhanced pain relief, fewer adverse side effects and faster relief of pain compared to other currently available treatments.
3
| Extinct | Pharmaceuticals: Major | 3 |
PolaRx Biopharmaceuticals
 PolaRx Biopharmaceuticals Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, PolaRx Biopharmaceuticals is a company that manufactures TriOxide drugs for the treatment of leukemia and other cancers. The company is based in New York, NY. The company was founded by Fred H. Mermelstein, Peter Morgan Kash, Raymond P. Warrell. PolaRx Biopharmaceuticals was acquired by CTI BioPharma Corp., part of Swedish Orphan Biovitrum AB from June 27, 2023 on January 13, 2000 for $17.50 million.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Paramount Capital Investments LLC
1
| Private Company | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Fred H. Mermelstein via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Director/Board Member | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Investment Managers | General Counsel Corporate Officer/Principal | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| McGill University Health Centre Foundation | Investment Trusts/Mutual Funds | Chief Executive Officer Director/Board Member | |
| DCML LLC | Founder Founder | ||
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Investment Managers | Director/Board Member Director/Board Member | |
| University of Virginia | College/University | Corporate Officer/Principal Masters Business Admin | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Doctorate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| Wayne State University (Michigan) | College/University | Undergraduate Degree Corporate Officer/Principal | |
VHS of Michigan, Inc.
 VHS of Michigan, Inc. Hospital/Nursing ManagementHealth Services The Detroit Medical Center's (DMC) record of service has provided medical excellence throughout the history of the Metropolitan Detroit area. From the founding of Children's Hospital in 1886, to the creation of the first mechanical heart at Harper Hospital 50 years ago. Their medical experts are nationally recognized and each year, hundreds of DMC doctors are included in the list of America's Best Doctors. A reputation for excellence draws patients to world-class programs in oncology, organ transplant, cardiology, women's services, neurosciences, stroke treatment, optometry, orthopedics, pediatrics and rehabilitation. They are the leading academically integrated system in metropolitan Detroit and the largest health care provider in southeast Michigan. The DMC has more than 2,000 licensed beds and 3,000 affiliated physicians. Detroit Medical Center facilities employ best practices and conduct business in an atmosphere of respect and professionalism. Their recognition of and attention to diversity in their business operations and healthcare services is unparalleled. Their volunteer efforts in health education & disease prevention represent an ongoing commitment to the health and well-being of the communities they serve. The DMC continues to meet the health care needs of a growing community, offering the best in medical research & development, advanced technology and optimum clinical services. | Hospital/Nursing Management | President Director/Board Member President | |
| Orion Biomedical Fund LP | Corporate Officer/Principal Corporate Officer/Principal | ||
Refined Sugars, Inc.
 Refined Sugars, Inc. Agricultural Commodities/MillingProcess Industries Part of Sugar Cane Growers Cooperative of Florida, Refined Sugars, Inc. is a company that manufactures refined sugar. The company is based in Yonkers, NY. Refined Sugars was acquired by Sugar Cane Growers Cooperative of Florida from ONEX Corp. on December 07, 1998. | Agricultural Commodities/Milling | Chairman | |
| McGill University | College/University | Corporate Officer/Principal Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Ottawa | College/University | Corporate Officer/Principal | |
McKesson Canada Corp.
 McKesson Canada Corp. Air Freight/CouriersTransportation McKesson Canada Corp. provides healthcare services. It provides pharmaceutical and strategic, automation solutions, and technological solutions. The company was founded in 1905 and is headquartered in Saint-Laurent, Canada. | Air Freight/Couriers | President | |
| Montreal Children’s Hospital Foundation | Director/Board Member | ||
McGill University Health Center
 McGill University Health Center Hospital/Nursing ManagementHealth Services McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada. | Hospital/Nursing Management | President Chairman | |
SOVAR, Inc.
 SOVAR, Inc. Miscellaneous Commercial ServicesCommercial Services SOVAR, Inc. provides development and commercialization of new technologies derived from university research and from partnering research centre. It specializes in identifying novel technologies and expertise derived from research activities, develop them and facilitate their transfer into useful and marketable applications. The company was founded in 2000 and is headquartered in St. Foy, Canada. | Miscellaneous Commercial Services | Chairman | |
Canadian Association For Pharmacy Distribution Management
 Canadian Association For Pharmacy Distribution Management Miscellaneous Commercial ServicesCommercial Services The Canadian Association for Pharmacy Distribution Management (CAPDM) is an organization that represents the healthcare distribution industry in Canada. The private company is based in Woodbridge, Canada. The Canadian company works to save the healthcare system money, safeguard product quality, handle product recalls, and mitigate drug shortage impact. CAPDM simplifies a complex and highly regulated system, driving system costs down and bringing value to the entire supply chain and ultimately patients. The company delivers over 95%% of all retail pharmaceuticals with 99.9+%% accuracy in order fulfillment, next day or sooner deliveries to most pharmacies, and up to 11 deliveries/week to pharmacies. David W. Johnston has been the CEO of the company since 2014. | Miscellaneous Commercial Services | Chairman | |
Barbara Ann Karmanos Cancer Institute
 Barbara Ann Karmanos Cancer Institute Hospital/Nursing ManagementHealth Services Barbara Ann Karmanos Cancer Institute provides health care services for cancer patients. It also provides integrated center of research, patient care and education, dedicated to the prevention, early detection, treatment and eventual eradication of cancer. The company was founded in 1943 and is headquartered in Detroit, MI. | Hospital/Nursing Management | Founder President | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Founder | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Genus Oncology LLC
 Genus Oncology LLC BiotechnologyHealth Technology Genus Oncology LLC operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing first-in-class agents against the MUC1-C oncoprotein for the treatment of patients with refractory cancers. The company was founded in 2007 and is headquartered in Chicago, IL. | Biotechnology | Director/Board Member | |
| Linus Pharmaceuticals, Inc. | Director/Board Member | ||
| METASTAT, INC. | Electrical Products | Chief Executive Officer Director/Board Member Investor Relations Contact | |
Folia Biotech, Inc.
 Folia Biotech, Inc. Drugstore ChainsRetail Trade FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada. | Drugstore Chains | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| C4 THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member Founder Director/Board Member | |
Business Council of Canada
 Business Council of Canada Miscellaneous Commercial ServicesCommercial Services Business Council of Canada provides program for research and consultation and advocacy of economic and social fabric. The company was founded in 1976 and is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Mana Therapeutics, Inc.
 Mana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mana Therapeutics, Inc. provides clinical cell immune therapies that can eliminate cancer cells. The company was founded by Catherine Bollard, Patrick Hanley, C. Russell Y. Cruz and Marc Cohen and is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Lightchain Capital LLC
 Lightchain Capital LLC Internet Software/ServicesTechnology Services Lightchain Capital LLC operates as single family office of Rodger Riney. It offers venture capital, software development and data science and has worked for major banks, investment firms and startups. The company was founded by Leo Semmelmann and Jan-Erik Flentje in 2007and is headquartered in St. Louis, MO. | Internet Software/Services | Corporate Officer/Principal Private Equity Investor | |
| Raqia Therapeutics, Inc. | Director/Board Member Director/Board Member | ||
AI Proteins, Inc.
 AI Proteins, Inc. Pharmaceuticals: MajorHealth Technology AI Proteins, Inc. is a biotech company based in Andover, MA. AI Proteins is focused on re-imagining protein therapeutics by designing entirely new proteins using an AI-based approach and a high-throughput drug discovery platform. The company's platform enables the development of inexpensive, durable, and highly specific proteins optimized for specific therapeutic applications. These proteins have the potential for oral delivery and can dramatically accelerate the development of lead therapeutic candidates ready for IND-enabling studies. The company was founded by Marc A. Cohen and Christopher Bahl. Noah D. Beerman has been the CEO of the company since 2023. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Microbial Machines, Inc. | Director/Board Member Chief Executive Officer Chief Executive Officer Founder |
Statistics
International
| United States | 36 |
| Canada | 16 |
Sectoral
| Health Technology | 13 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Health Services | 5 |
| Finance | 4 |
Operational
| Director/Board Member | 320 |
| Corporate Officer/Principal | 124 |
| Chairman | 60 |
| President | 56 |
| Independent Dir/Board Member | 54 |
Most connected contacts
| Insiders | |
|---|---|
| Robert S. Saunders | 32 |
| Peter Morgan Kash | 32 |
| Douglas G. Watson | 30 |
| Bobby Sandage | 29 |
| Peter Karmanos | 27 |
| Neil William Flanzraich | 25 |
| Arthur T. Porter | 22 |
| Stephen Rocamboli | 20 |
| William McKee | 20 |
| Sidney R. Knafel | 18 |
| Georg Nebgen | 18 |
| Kenneth Anderson | 17 |
| Marc Rubin | 17 |
| Douglas A. Hamilton | 16 |
| Martin Driscoll | 16 |
- Stock Market
- Insiders
- Fred H. Mermelstein
- Company connections
